What are the possible causes of low urinary catecholamine levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Reasons for Low Urinary Catecholamine Levels

Low urinary catecholamine levels most commonly result from incomplete urine collection, chronic renal failure, autonomic nervous system dysfunction (particularly autonomic synucleinopathies), renal denervation, or secondary adrenocortical insufficiency.

Pre-Analytical and Collection Issues

The most frequent cause of falsely low urinary catecholamines in clinical practice is incomplete 24-hour urine collection. When measuring urinary catecholamines or metanephrines, urinary creatinine must be measured simultaneously to verify collection completeness 1. This is a critical quality control step that should never be omitted.

Common pitfall: Always calculate the expected 24-hour creatinine excretion (15-20 mg/kg/day for women, 20-25 mg/kg/day for men) to identify inadequate collections before interpreting catecholamine results.

Renal Dysfunction

Chronic renal failure significantly reduces urinary catecholamine excretion, particularly affecting norepinephrine and dopamine outputs 2. The excretion of norepinephrine and dopamine correlates positively with creatinine clearance, with normal outputs only seen when clearance exceeds 40 mL/min 2.

  • Patients with impaired renal function show markedly decreased free catecholamine output
  • This effect must be considered when interpreting values that may have pathological significance
  • Adrenaline output shows less correlation with creatinine clearance but remains lower than normal in renal failure 2

Autonomic Nervous System Disorders

Autonomic synucleinopathies cause decreased urinary excretion of both norepinephrine and dopamine 3. This includes:

  • Parkinson's disease: Significantly decreased norepinephrine (p=0.0001) and dopamine (p=0.0136) excretion
  • Pure autonomic failure: Markedly decreased norepinephrine (p<0.0001) and dopamine (p=0.0027) excretion
  • Multiple system atrophy: Decreased norepinephrine (p<0.0001) and dopamine (p=0.0344) excretion

The mechanism involves dysfunction in both the renal sympathetic noradrenergic system and the DOPA-dopamine autocrine-paracrine system 3.

Renal Denervation

Surgical or pathological renal denervation reduces urinary catecholamine excretion by approximately two-thirds 4. Studies in renal transplant recipients demonstrate:

  • Norepinephrine and dopamine appear in urine at only one-third the rate of innervated kidneys
  • Almost all urinary dopamine originates from the kidney itself
  • Two-thirds of renal norepinephrine and dopamine depend on intact renal nerve supply 4

This is particularly relevant when interpreting results in transplant recipients or patients with autonomic neuropathy affecting renal innervation.

Adrenocortical Insufficiency

Secondary adrenocortical insufficiency causes reduced epinephrine excretion proportional to the decrease in cortisol secretion 5. In patients with panhypopituitarism:

  • Mean urinary epinephrine excretion falls to the lower limit of normal
  • A highly significant positive correlation exists between cortisol levels and epinephrine excretion
  • Norepinephrine excretion remains relatively preserved 5

Physiological Factors

Several demographic and physiological factors affect catecholamine levels 6:

  • Age: Increasing age predicts increased plasma and urinary norepinephrine
  • Sex: Female sex predicts lower urinary and plasma epinephrine
  • Dietary sodium: Sodium restriction increases both plasma and urinary norepinephrine (strongest effect)
  • Body mass index and race: Variable effects on different catecholamines

Clinical Context

Important note: When evaluating for catecholamine-secreting tumors (pheochromocytoma/paraganglioma), measurements of plasma free metanephrines or urinary fractionated metanephrines are superior to catecholamines themselves 1. Metanephrines are produced continuously within tumors independent of episodic catecholamine release, providing 97% sensitivity compared to 47-74% for catecholamines alone 1.

Key caveat: Low urinary catecholamines effectively rule out pheochromocytoma only when the collection is verified as complete and renal function is normal. In the presence of renal dysfunction or autonomic disorders, metanephrine measurements become even more critical for diagnosis.

References

Guideline

pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

Research

Urinary catecholamine excretion in relation to renal function.

Annals of clinical biochemistry, 1999

Research

Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.